Enfermedad meningocócica.Un estudio de caso control en Ciudad Habana, noviembre 2003-julio 2005 by Antonio Pérez, Rosa Zamora, Rolando Pajón

Get full text

Human Factor H (FH) Impairs Protective Meningococcal Anti-FHbp Antibody Responses and the Antibodies Enhance FH Binding by Isabella Costa, Rolando Pajon, Dan M. Granoff

Get full text

Comparing the similarity of different groups of bacteria to the human proteome. by Brett Trost, Rolando Pajon, Teenus Jayaprakash, Anthony Kusalik

Get full text

Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine development. by Rolando Pajon, Andrew M Fergus, Oliver Koeberling, Dominique A Caugant, Dan M Granoff

Get full text

The effect of human factor H on immunogenicity of meningococcal native outer membrane vesicle vaccines with over-expressed factor H binding protein. by Peter T Beernink, Jutamas Shaughnessy, Rolando Pajon, Emily M Braga, Sanjay Ram, Dan M Granoff

Get full text

Predicted proteins of Neisseria meningitidis as potential vaccine candidates: from in silico analyses to experimental corroboration by Darien García, Daniel Yero, Olivia Niebla, Karem Cobas, Yasser Perera, Evelin Caballero, Maite Delgado, Rolando Pajón

Get full text

Clinical Utility of Elecsys Anti-SARS-CoV-2 S Assay in COVID-19 Vaccination: An Exploratory Analysis of the mRNA-1273 Phase 1 Trial by Simon Jochum, Imke Kirste, Sayuri Hortsch, Veit Peter Grunert, Holly Legault, Udo Eichenlaub, Basel Kashlan, Rolando Pajon

Get full text

Profiling antibody epitopes induced by mRNA-1273 vaccination and boosters by Bethany Girard, Elisabeth Baum-Jones, Rebecca L. Best, Thomas W. Campbell, Jack Coupart, Kyla Dangerfield, Abhilash Dhal, Michael Jhatro, Brian Martinez, Jack Reifert, John Shon, Minlu Zhang, Rebecca Waitz, Spyros Chalkias, Darin K. Edwards, Maha Maglinao, Robert Paris, Rolando Pajon

Get full text

Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation by Yunda Huang, Oleg Borisov, Jia Jin Kee, Lindsay N. Carpp, Terri Wrin, Suqin Cai, Marcella Sarzotti-Kelsoe, Charlene McDanal, Amanda Eaton, Rolando Pajon, John Hural, Christine M. Posavad, Katherine Gill, Shelly Karuna, Lawrence Corey, M. Juliana McElrath, Peter B. Gilbert, Christos J. Petropoulos, David C. Montefiori

Get full text

Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial by Ying Huang, Nima S. Hejazi, Bryan Blette, Lindsay N. Carpp, David Benkeser, David C. Montefiori, Adrian B. McDermott, Youyi Fong, Holly E. Janes, Weiping Deng, Honghong Zhou, Christopher R. Houchens, Karen Martins, Lakshmi Jayashankar, Britta Flach, Bob C. Lin, Sarah O’Connell, Charlene McDanal, Amanda Eaton, Marcella Sarzotti-Kelsoe, Yiwen Lu, Chenchen Yu, Avi Kenny, Marco Carone, Chuong Huynh, Jacqueline Miller, Hana M. El Sahly, Lindsey R. Baden, Lisa A. Jackson, Thomas B. Campbell, Jesse Clark, Michele P. Andrasik, James G. Kublin, Lawrence Corey, Kathleen M. Neuzil, Rolando Pajon, Dean Follmann, Ruben O. Donis, Richard A. Koup, Peter B. Gilbert, on behalf of the Immune Assays, Moderna, Inc., Coronavirus Vaccine Prevention Network (CoVPN)/Coronavirus Efficacy (COVE), United States Government (USG)/CoVPN Biostatistics Teams

Get full text